Patent ID: 9198954
Filing Date: 2015-12-01
Classification: A61K,A61P,C07K

Abstract:
1. A pharmaceutical composition for injection, the composition being free of citrate, comprising: (a) anakinra (about 100 mg/ml-about 200 mg/ml); (b) EDTA (about 0.05 mM-about 1 mM); (c) polysorbate 80 (about 0.01%-about 1% (w/w)); (d) NaCl (about 120 mM-about 180 mM); (e) sodium phosphate, pH 6-7 (about 1 mM-about 50 mM); and (f) mannitol (about 5 mg/ml-about 50 mg/ml), wherein the pharmaceutical composition is suitable for injection in a subject in need thereof.